The Centers for Medicare & Medicaid Services (CMS) is ending a subsidy that helped Medicare Part D drug plans cover low-income beneficiaries. The subsidy, which offset costs for plans serving high proportions of low-income seniors, provided financial relief as drug prices rose. Its elimination forces insurers to absorb costs or reduce plan offerings.
CMS Ends Medicare Part D Subsidy—Insurers Face Pressure
Drug plan insurers lose federal support, squeezing margins on low-income beneficiaries.

| Ticker | Company | 1-year change |
|---|---|---|
| UNH | UnitedHealth | +20.3% |
Subsidy elimination forces Medicare Part D insurers to choose between margin compression and market exit.
Medicare Part D insurers—UnitedHealth Group UNH, Humana HUM, CVS Health CVS, Anthem (ANTM)—face margin compression. Low-income beneficiaries are costlier to serve (higher disease burden, medication complexity), and the subsidy offset that cost. Without it, insurers must either raise premiums (risking enrollment loss), reduce plan quality, or exit markets. Smaller regional insurers, which often serve higher proportions of low-income members, face the sharpest pressure and may exit Part D entirely.
Pharmacy benefit managers (PBMs) and drug manufacturers face indirect pressure. If insurers reduce plan offerings or raise cost-sharing, beneficiary access to medications declines, reducing pharmacy volume and drug sales. However, this is a secondary effect.
Watch for insurer guidance revisions and any announcements of Part D plan exits or premium increases. Also monitor whether Congress restores the subsidy or provides alternative relief, which would reverse the pressure.
Source: original report ↗
Free: catalyst alerts, straight to your inbox.
Get the White House orders, federal contracts, and FDA decisions that move money — with who cashes in — free. Unsubscribe in one click.
Free · weekly · unsubscribe anytime. Privacy.
Stay three moves ahead of every practice in your market.
Knowing it happened is table stakes. Money Racket Pro hands you the play — what each move means for your margins, your license, and your patients, and exactly what to do about it — in a two-minute brief, twice a week. The owners who read it never get blindsided.
Get the edge · $40/moJoin the owners who run ahead of the industry. Cancel anytime, one click.